Clinical trials recruiting for Cutaneous Squamous Cell Carcinoma
9
Recruiting trials
17
US states with sites
7
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Pembrolizumab | 2 |
| BCA101 | 1 |
| Cemiplimab | 1 |
| Cosibelimab | 1 |
| Docetaxel | 1 |
| Everolimus | 1 |
| IDP-001 | 1 |
| Ivonescimab | 1 |
| MDNA11 | 1 |
| MEM-288 Intratumoral Injection | 1 |
| MQ719 | 1 |
| Nivolumab | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 4 |
| Texas | 4 |
| California | 3 |
| Massachusetts | 3 |
| New York | 3 |
| North Carolina | 2 |
| Pennsylvania | 2 |
| Georgia | 1 |
| Indiana | 1 |
| Maryland | 1 |
| Michigan | 1 |
| New Jersey | 1 |
Top cities
Boston, Massachusetts 3Houston, Texas 3Los Angeles, California 2New York, New York 2Pittsburgh, Pennsylvania 2Tampa, Florida 2Atlanta, Georgia 1Basking Ridge, New Jersey 1Bethesda, Maryland 1Boca Raton, Florida 1
Self-screener
Recruiting trials
- A Beta-only IL-2 ImmunoTherapY Study
- A Study of IDP-001 in Advanced or Metastatic Solid Tumors
- A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
- Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
- MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
- Personalised Immunotherapy Platform
- Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma
- Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
- Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Related conditions
Trials recruiting for Cutaneous Squamous Cell Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Merkel Cell Carcinoma 12Melanoma 487Lung cancer 2180Pancreatic cancer 870Head and Neck Squamous Cell Carcinoma 42Basal Cell Carcinoma 6Triple-negative breast cancer 138Squamous Cell Carcinoma of Head and Neck 11Skin Cancer 23Non-small cell lung cancer 507
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Cutaneous Squamous Cell Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.